Cells called alveolar myofibroblasts, which have a central role in the development of the lung after birth, receive an orchestrated input from a range of different signaling pathways.

shedding light on potential pathways through which aging may promote lung cancer ... Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung ...

Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...

The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same ...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Lung cancer is the third most common type of cancer diagnosed in the United States but is the deadliest cancer in our country ...

Cancer cells impair monocyte-mediated T-cell activation by disrupting inflammatory pathways in the tumor microenvironment.

Aging induces iron deficiency, reducing stem cell function and tumor growth while enhancing ferroptosis resistance, revealing ...

Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

The FDA approved Bizengri (zenocutuzumab-zbco) for advanced unresectable or metastatic NRG1+ NSCLC or pancreatic adenocarcinoma.